| FIFGX | PCLIX | FIFGX / PCLIX | |
| Total Expense Ratio | 0.39 | 0.82 | 48% |
| Annual Report Gross Expense Ratio | 0.39 | 0.98 | 40% |
| Fund Existence | 7 years | 16 years | - |
| Gain YTD | 8.948 | 6.691 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.52B | 4.8B | 115% |
| Annual Yield % from dividends | 7.49 | 4.68 | 160% |
| Returns for 1 year | 10.79 | 8.16 | 132% |
| Returns for 3 years | 1.56 | 15.60 | 10% |
| Returns for 5 years | 49.44 | 105.98 | 47% |
| Returns for 10 years | N/A | 154.92 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GQEFX | 35.42 | 0.07 | +0.20% |
| GMO Quality IV | |||
| CGJAX | 75.55 | 0.10 | +0.13% |
| Calvert US Large Cap Growth Rspnb Idx A | |||
| JIESX | 20.50 | 0.01 | +0.05% |
| JPMorgan Developed International Value I | |||
| VICVX | 22.62 | -0.01 | -0.04% |
| USA Mutuals Vice Institutional | |||
| ITETX | 10.34 | -0.15 | -1.43% |
| VY® T. Rowe Price Equity Income S2 | |||